Pfizer plans to launch Prevnar 20, a new pneumococcal vaccine, in Korea early next year, offering broader protection than ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

Drug manufacturers saw their stock prices fall on Friday after vaccine skeptic Robert F. Kennedy Jr. was announced as Trump's ...

Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

A woman sued Pfizer, alleging the birth control shot Depo-Provera caused her brain tumors, following a study linking the drug ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...

The European Commission refused to hand over text messages its president sent to Pfizer Inc.’s boss at the height of the ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

Several people were evaluated by paramedics at the scene and one firefighter was taken to a local hospital “as a precaution,” ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.